Practice

Latest News

doctor talking about biosimilars | Image credit: Suteren Studio - stock.adobe.com
Real-World Study: No Increase in Health Resource Costs After Infliximab Biosimilar Introduction

July 20th 2024

Although biosimilars reduce drug purchasing costs for hospitals, it’s unclear whether those savings might be offset by increased health resource utilization following a non-medical switching initiative.

Rheumatoid arthritis treatment. | Image Credit: MicroOne - stock.adobe.com
Biosimilar DMARDs Offer Cost-Effective Option for Patients With RA After Failed Methotrexate Treatment

July 15th 2024

doctor with breast cancer ribbon | Image credit: Romolo Tavani - stock.adobe.com
Trastuzumab-dkst Shows Promising Results in Real-World Setting for HER2+ Breast Cancer

July 9th 2024

hematology and oncology | Image credit: Anusorn - stock.adobe.com
EHA 2024: Rituximab Biosimilars Improve Quality of Life, Infusion-Related Reactions

June 27th 2024

UK healthcare and biosimilars | Image credit: millaf - stock.adobe.com
Biosimilar Adoption in the UK: Patient and Consultant Views on Safety and Switching

June 26th 2024

Video Interviews
Podcasts
CFB podcast banner
cfb podcast banner
CfB podcast banner
CfB podcast barrier
CfB podcast banner
CfB podcast banner
CfB podcast banner
podcast banner
CfB podcast banner
CfB podcast banner

More News

© 2024 MJH Life Sciences

All rights reserved.